Modulation of the Microtubule Network for Optimization of Nanoparticle Dynamics for the Advancement of Cancer Nanomedicine

Published on Jun 14, 2020in Bioengineering
· DOI :10.3390/BIOENGINEERING7020056
Aaron Bannister3
Estimated H-index: 3
(UVic: University of Victoria),
Dushanthi Dissanayake1
Estimated H-index: 1
(UVic: University of Victoria)
+ 3 AuthorsDevika B. Chithrani17
Estimated H-index: 17
(UVic: University of Victoria)
Sources
Abstract
Nanoparticles (NPs) have shown promise in both radiotherapy and chemotherapy. NPs are mainly transported along cellular microtubules (MTs). Docetaxel (DTX) is a commonly used chemotherapeutic drug that can manipulate the cellular MT network to maximize its clinical benefit. However, the effect of DTX on NP behaviour has not yet been fully elucidated. We used gold NPs of diameters 15 and 50 nm at a concentration of 0.2 nM to investigate the size dependence of NP behaviour. Meanwhile, DTX concentrations of 0, 10 and 50 nM were used to uphold clinical relevance. Our study reveals that a concentration of 50 nM DTX increased NP uptake by ~50% and their retention by ~90% compared to cells treated with 0 and 10 nM DTX. Smaller NPs had a 20-fold higher uptake in cells treated with 50 nM DTX vs. 0 and 10 nM DTX. With the treatment of 50 nm DTX, the cells became more spherical in shape, and NPs were redistributed closer to the nucleus. A significant increase in NP uptake and retention along with their intracellular distribution closer to the nucleus with 50 nM DTX could be exploited to target a higher dose to the most important target, the nucleus in both radiotherapy and chemotherapy.
Download
📖 Papers frequently viewed together
201610.32Biomaterials
12 Authors (He-Lin Xu, ..., Ying-Zheng Zhao)
32 Citations
8 Citations
9 Citations
References51
Newest
#1Aaron Bannister (UVic: University of Victoria)H-Index: 3
#2Kyle Bromma (UVic: University of Victoria)H-Index: 7
Last. Devika B. ChithraniH-Index: 17
view all 9 authors...
Objective:One of the major issues in current radiotherapy (RT) is the normal tissue toxicity. A smart combination of agents within the tumor would allow lowering the RT dose required while minimizi...
8 CitationsSource
#1Kristy Rieck (UVic: University of Victoria)H-Index: 2
#2Kyle Bromma (UVic: University of Victoria)H-Index: 7
Last. Devika B. Chithrani (UVic: University of Victoria)H-Index: 17
view all 6 authors...
Objective: The incorporation of high atomic number materials such as gold nanoparticles (GNPs) into tumor cells is being tested to enhance the local radiotherapy (RT) dose. It is also known that th...
5 CitationsSource
#1Behafarid Ghalandari (IAU: Islamic Azad University)H-Index: 14
#2Kazem Asadollahi (UT: University of Tehran)H-Index: 3
Last. Neda Attaran (IAU: Islamic Azad University)H-Index: 11
view all 7 authors...
Abstract Photothermal therapy is achieving ever-increasing attention as a promising method for killing cancer cells. Although, gold nanoparticles are regarded as one of the most effective photothermal therapy agents, the mechanisms underlying their action have to be addressed. Moreover, studies have showed that gold nanoparticles induce apoptosis in treated cultures. Hence, in this study, we investigated the interaction of folic acid functionalized gold nanoparticles and gold-shelled Fe3O4 nanop...
9 CitationsSource
#1Celina Yang (RyeU: Ryerson University)H-Index: 8
#2Kyle Bromma (UVic: University of Victoria)H-Index: 7
Last. Devika B. Chithrani (RyeU: Ryerson University)H-Index: 17
view all 3 authors...
Optimizing the interface between nanoparticles (NPs) and the biological environment at various levels should be considered for improving delivery of NPs to the target tumor area. For NPs to be successfully delivered to cancer cells, NPs needs to be functionalized for circulation through the blood vessels. In this study, accumulation of Polyethylene Glycol (PEG) functionalized gold nanoparticles (GNPs) was first tested using in vitro monolayer cells and multilayer cell models prior to in vivo mod...
15 CitationsSource
: Nanomedicine is a relatively new and rapidly evolving field combining nanotechnology with the biomedical and pharmaceutical sciences.1-3 Nanoparticles (NPs) can impart many pharmacokinetic, efficacy, safety, and targeting benefits when they are included in drug formulations.1-5 Many nanodrugs have entered clinical practice, and even more are being investigated in clinical trials for a wide variety of indications.2 However, nanopharmaceuticals also face challenges, such as the need for better c...
251 Citations
#1Ping-Hsiu WuH-Index: 3
#2Yasuhito Onodera (Hokkaido University)H-Index: 15
Last. Jin-Min Nam (Hokkaido University)H-Index: 11
view all 10 authors...
: Gold nanoparticles (AuNPs) have recently attracted attention as clinical agents for enhancing the effect of radiotherapy in various cancers. Although radiotherapy is a standard treatment for cancers, invasive recurrence and metastasis are significant clinical problems. Several studies have suggested that radiation promotes the invasion of cancer cells by activating molecular mechanisms involving integrin and fibronectin (FN). In this study, polyethylene-glycolylated AuNPs (P-AuNPs) were conjug...
39 CitationsSource
#1Kari Barlan (U of C: University of Chicago)H-Index: 8
#2Vladimir I. Gelfand (NU: Northwestern University)H-Index: 59
: SUMMARYMicrotubules provide long tracks along which a broad range of organelles and vesicles are transported by kinesin and dynein motors. Motor protein complexes also tether cargoes to cytoskeletal filaments, helping facilitate their interaction and communication. The generation of biochemically distinct microtubule subpopulations allows subsets of motors to recognize a given microtubule identity, allowing further organization within the cytoplasm. Both transport and tethering are spatiotempo...
65 CitationsSource
#1Giulio F. PaciottiH-Index: 11
#2Jielu Zhao (VT: Virginia Tech)H-Index: 3
Last. David G. I. Kingston (VT: Virginia Tech)H-Index: 71
view all 9 authors...
The synthesis of a series of thiolated paclitaxel analogs is described as part of a novel nanomedicine program aimed at developing formulations of paclitaxel that will bind to gold nanoparticles for tumor targeted drug delivery. Preliminary evaluation of the new nanomedicine composed of 27 nm gold nanoparticles, tumor necrosis factor alpha (TNFα), thiolated polyethylene glycol (PEG-thiol), and one of several thiolated paclitaxel analogs is presented.
40 CitationsSource
#1Daniel Bobo (UQ: University of Queensland)H-Index: 1
#2Kye J. Robinson (Monash University)H-Index: 6
Last. Simon R. Corrie (Monash University)H-Index: 19
view all 5 authors...
In this review we provide an up to date snapshot of nanomedicines either currently approved by the US FDA, or in the FDA clinical trials process. We define nanomedicines as therapeutic or imaging agents which comprise a nanoparticle in order to control the biodistribution, enhance the efficacy, or otherwise reduce toxicity of a drug or biologic. We identified 51 FDA-approved nanomedicines that met this definition and 77 products in clinical trials, with ~40% of trials listed in clinicaltrials.go...
942 CitationsSource
#1Marc Hafner (Harvard University)H-Index: 20
#2Mario Niepel (Harvard University)H-Index: 28
Last. Peter K. Sorger (Harvard University)H-Index: 101
view all 4 authors...
Growth inhibition metrics allow for robust measurement of drug efficacy independent of variables such as cell growth rate, seeding density, and growth medium; they are a practical alternative to metrics such as IC50 and offer enhanced reproducibility.
237 CitationsSource
Cited By1
Newest
About half of cancer patients (50%) receive radiotherapy (RT) for the treatment of local tumors. However, one of the main obstacles in RT is the close proximity of adjacent organs at risk, resulting in treatment doses being limited by significant tissue toxicity, hence preventing the necessary dose escalation that would guarantee local control. Effective local cancer therapy is needed to avoid progression of tumors and to decrease the development of systemic metastases which may further increase...
Source